Regional Sales Manager
No salary listed
Senior
Houston, TX, USA
In PersonBased in Houston or Chicago; more than 50% travel across the Midwest, to conferences, and to company headquarters in Boston.
Sales & Account ManagementField Sales
About the job
Requirements
- At least five years of life sciences sales experience focused on capital equipment and fee-for-service sales.
- A prospecting mindset, with demonstrated success in territory planning, pipeline management, and closing deals.
- Technical expertise in genomics, spatial biology, and/or imaging technologies.
- Experience selling to academic, biotech, and pharmaceutical customers, engaging with scientists, core facilities, and procurement teams.
- Proficiency with customer relationship management and artificial intelligence tools for sales operations and reporting.
- Ability to present scientific demonstrations and seminars.
- Ability to work in a constantly changing, high-growth environment.
- Ability to travel at least 50% across the Midwest Region, to conferences, and to company headquarters in Boston.
Responsibilities
- Manage the full sales cycle, from prospecting to closing, with a focus on capital equipment.
- Identify and cultivate new business opportunities across academic, biotech, and pharmaceutical sectors.
- Conduct on-site meetings, demonstrations, and presentations across the Midwest.
- Understand customers’ scientific projects and business needs to position the company’s solutions effectively.
- Use product knowledge to conduct sales presentations and support instrument and reagent sales.
- Develop and execute territory sales plans, using market insights and customer feedback to refine strategies.
- Communicate with internal teams and external stakeholders, gathering customer insights to inform product development and innovation.
- Work with marketing, research and development, and field teams to enhance customer success and drive adoption.
- Explore new technology applications and expand market reach in an emerging field.
- Build relationships with core facilities and decision-makers to increase awareness and engagement.
- Represent the company professionally, ethically, and responsibly, providing customer experiences that support long-term partnerships.
About the company
Stellaromics provides tools for 3D tissue analysis by reading multiple molecular layers at once. Its Pyxa platform enables three-dimensional spatial multi-omics to map gene expression across tissues. A core component, STARmap, measures thousands of genes in a tissue sample to reveal cellular function and organization in 3D. The company sells the Pyxa platform and services to research institutions and pharma collaborators to advance neuroscience and cancer research.
Company Size
51-200
Company Stage
Series B
Total Funding
$105M
Headquarters
Natick, Massachusetts
Founded
2022
Get referred to Stellaromics
See people who can refer or advise you
Simplify's Take
What believers are saying
- Commercial placements at Mount Sinai, CNAG, Karolinska, and Stanford validate demand.
- Leadership hires Veronica Mankinen and John Leamon strengthened sales and product execution in May 2026.
- RIBOmap and protein co-detection launches in late 2026 expand wallet share beyond RNA.
What critics are saying
- 10x Genomics, Bruker, and Vizgen crowd out Pyxa with larger commercial footprints.
- Pyxa still sells through limited Early Access, delaying broad revenue conversion in 2026.
- If instruments lag reagent pull-through, capital equipment weakness can choke the company by 2027.
What makes Stellaromics unique
- Pyxa launched February 19, 2026 as first commercial true 3D spatial multi-omics platform.
- Pyxa images intact tissue up to 100 micrometers, preserving architecture lost in 2D methods.
- Stellaromics' STARmap lineage and Stanford-MIT roots give it deep technical credibility.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options